Spectroscopic Characterization, Cyclic Voltammetry, Biological Investigations, MOE, and Gaussian Calculations of VO(II), Cu(II), and Cd(II) Heteroleptic Complexes

A novel hydrazone ligand (o-H₂BMP) N-(benzo[d]thiazol-2-yl)-3-oxo-3-(2-(1-(pyridin-2-yl)ethylidene)hydrazinyl)propanamide alongside its Cu(II), Cd(II), and VO(II) complexes were prepared and structurally characterized via various spectroscopic analyses (Fourier transform infrared spectroscopy, UV-visible spectroscopy, ¹H/¹³C NMR spectroscopy, liquid chromatography coupled to mass spectrometry, and electron paramagnetic resonance spectroscopy) as well as by elemental analysis, thermal gravimetry analysis/differential thermal analysis, and magnetic moment measurements. Powder X-ray diffraction analysis was also performed for the free ligand and its metal complexes to determine the crystallographic structures and atomic spacing. It also provided information on unit cell dimensions and the average crystallite size. Furthermore, geometric optimization and computational studies were carried out by applying Gaussian (09) software based on density-functional theory coupled with the B3LYP functional and LANL2DZ/6-31+G(d,p) mixed basis set to evaluate some distinct features such as molecular electrostatic potential, E _HOMO, and E _LUMO. Moreover, electrochemical measurements were performed for Cu(II) in the absence/presence of the chelating agent to predict the effect of complexation interaction in the solution state study. As part of the biological examination, antioxidant and antimicrobial assays were conducted for each compound individually, in addition to cytotoxicity evaluations via MTT assays for all isolated complexes compared to the corresponding metal salts. The MOE (molecular operating environment) approach was also applied to model the interface between the isolated compounds and proteins that were expressed in breast cancer at the atomic level.

Heterobimetallic Ru(II)/M (M = Ag+, Cu2+, Pb2+) Complexes as Photosensitizers for Room-Temperature Gas Sensing

This work is devoted to the investigation of heterobimetallic Ru(II) complexes as photosensitizers for room-temperature photoactivated In₂O₃-based gas sensors. Nanocrystalline In₂O₃ was synthesized by the chemical precipitation method. The obtained In₂O₃ matrix has a single-phase bixbyite structure with an average grain size of 13–14 nm and a specific surface area of 72 ± 3 m²/g. The synthesis of new ditope ligands with different coordination centers, their ruthenium complexes, and the preparation of heterobimetallic complexes with various cations of heavy and transition metals (Ag⁺, Pb²⁺, or Cu²⁺) is reported. The heterobimetallic Ru(II) complexes were deposited onto the surface of the In₂O₃ matrix by impregnation. The obtained hybrid materials were characterized by X-ray fluorescent analysis, FTIR spectroscopy, and optical absorption spectroscopy. The elemental distribution on the hybrids was characterized by energy-dispersive X-ray spectroscopy (EDS) mapping. The gas sensor properties were investigated toward NO₂, NO, and NH₃ at room temperature under periodic blue LED irradiation. It was identified that the nature of the second binding cation in Ru(II) heterobimetallic complexes can influence the selectivity toward different gases. Thus, the maximum sensor signal for oxidizing gases (NO₂, NO) was obtained for hybrids containing Ag⁺ or Pb²⁺ cations while the presence of Cu²⁺ cation results in the highest and reversible sensor response toward ammonia. This may be due to the specific adsorption of NH₃ molecules on Cu²⁺ cations. On the other hand, Cu²⁺ ions are proposed to be active sites for the reduction of nitrogen oxides to N₂. This fact leads to a significant decrease in the sensor response toward NO₂ and NO gases.

Systematic Variation of 3d Metal Centers in a Redox-Innocent Ligand Environment: Structures, Electrochemical Properties, and Carbon Dioxide Activation

Coordination compounds of earth-abundant 3d transition metals are among the most effective catalysts for the electrochemical reduction of carbon dioxide (CO₂). While the properties of the metal center are crucial for the ability of the complexes to electrochemically activate CO₂, systematic variations of the metal within an identical, redox-innocent ligand backbone remain insufficiently investigated. Here, we report on the synthesis, structural and spectroscopic characterization, and electrochemical investigation of a series of 3d transition-metal complexes [M = Mn(I), Fe(II), Co(II), Ni(II), Cu(I), and Zn(II)] coordinated by a new redox-innocent PNP pincer ligand system. Only the Fe, Co, and Ni complexes reveal distinct metal-centered electrochemical reductions from M(II) down to M(0) and show indications for interaction with CO₂ in their reduced states. The Ni(0) d¹⁰ species associates with CO₂ to form a putative Aresta-type Ni-η²-CO₂ complex, where electron transfer to CO₂ through back-bonding is insufficient to enable electrocatalytic activity. By contrast, the Co(0) d⁹ intermediate binding CO₂ can undergo additional electron uptake into a formal cobalt(I) metallacarboxylate complex able to promote turnover. Our data, together with the few literature precedents, single out that an unsaturated coordination sphere (coordination number = 4 or 5) and a d⁷-to-d⁹ configuration in the reduced low oxidation state (+I or 0) are characteristics that foster electrochemical CO₂ activation for complexes based on redox-innocent ligands.

A series of 3d transition-metal complexes (M = Mn, Fe, Co, Ni, Cu, and Zn) coordinated by a new redox-innocent PNP pincer ligand system were synthesized and structurally as well as electrochemically analyzed to illuminate the role of the metal center in molecular electrochemical carbon dioxide (CO₂) activation.

Triapine Analogues and Their Copper(II) Complexes: Synthesis, Characterization, Solution Speciation, Redox Activity, Cytotoxicity, and mR2 RNR Inhibition

Three new thiosemicarbazones (TSCs) HL¹–HL³ as triapine analogues bearing a redox-active phenolic moiety at the terminal nitrogen atom were prepared. Reactions of HL¹–HL³ with CuCl₂·2H₂O in anoxic methanol afforded three copper(II) complexes, namely, Cu(HL¹)Cl₂ (1), [Cu(L²)Cl] (2′), and Cu(HL³)Cl₂ (3), in good yields. Solution speciation studies revealed that the metal-free ligands are stable as HL¹–HL³ at pH 7.4, while being air-sensitive in the basic pH range. In dimethyl sulfoxide they exist as a mixture of E and Z isomers. A mechanism of the E/Z isomerization with an inversion at the nitrogen atom of the Schiff base imine bond is proposed. The monocationic complexes [Cu(L^1–3)]⁺ are the most abundant species in aqueous solutions at pH 7.4. Electrochemical and spectroelectrochemical studies of 1, 2′, and 3 confirmed their redox activity in both the cathodic and the anodic region of potentials. The one-electron reduction was identified as metal-centered by electron paramagnetic resonance spectroelectrochemistry. An electrochemical oxidation pointed out the ligand-centered oxidation, while chemical oxidations of HL¹ and HL² as well as 1 and 2′ afforded several two-electron and four-electron oxidation products, which were isolated and comprehensively characterized. Complexes 1 and 2′ showed an antiproliferative activity in Colo205 and Colo320 cancer cell lines with half-maximal inhibitory concentration values in the low micromolar concentration range, while 3 with the most closely related ligand to triapine displayed the best selectivity for cancer cells versus normal fibroblast cells (MRC-5). HL¹ and 1 in the presence of 1,4-dithiothreitol are as potent inhibitors of mR2 ribonucleotide reductase as triapine.

Three triapine analogues HL¹−HL³ bearing a phenolic redox-active moiety showed moderate antiproliferative activity, while one of the oxidation products HL^2c′·CH3COOH revealed high cytotoxicity in Colo205 and Colo320 cancer cell lines. Coordination of HL¹−HL³ to copper(II) increased strongly the cytotoxicity, with complex 2′ showing IC₅₀ values of 0.181 and 0.159, respectively. The highest cytotoxicity of 2′ is likely due to the highest thermodynamic stability, more negative reduction potential, and the lowest rate of reduction by GSH.

Development and demonstration of functionalized inorganic-organic hybrid copper phosphate nanoflowers for mimicking the oxidative reactions of metalloenzymes by working as a nanozyme

Copper phosphate nanoflowers (CuPNFs) have been synthesized in the presence of different aromatic phenanthroline derivatives (Ln), leading to inorganic-organic hybrid materials (Ln-CuPNFs). Studies revealed that the morphology of nanoflowers varies as a function of the aromatic moiety present in the derivative, Ln (where 'n' corresponds to phenyl, naphthyl, anthracenyl, and pyrenyl) used for coating the nanomaterial. Other noticeable changes were the increase in the size of the flower by ∼2-3 fold in the presence of these derivatives. In the absence of such aromatic phenanthroline derivatives, i.e., the use of 1,10-phenanthroline-5-amine did not induce the formation of nanoflowers, suggesting that the organic derivatization used in the present study stabilizes the nanoflower structure. Nanoflowers were characterized using X-ray diffraction, Brunauer-Emmett-Teller (BET) isotherm, X-ray photoelectron spectroscopy, Raman and Infrared spectroscopy, scanning electron microscopy, and transmission electron microscopy, thus covering a range of diffraction, spectroscopy, and microscopy techniques. Nanoflowers, Ln-CuPNFs, have been demonstrated for the oxidative reactions mimicking copper metalloenzymes in the presence and absence of hydrogen peroxide using different substrates. Thus, hybrid Ln-CuPNFs mediate the complete oxidation of o-phenylenediamine, dopamine, ascorbate oxidase, and terephthalic acid without causing much change in the morphology of the hybrid nanoflower material and with the retention of the activity supporting the hybrid as an acceptable enzyme mimicking material. Oxidation is mediated through hydroxyl radical formation and the order of the oxidative activity is pyrenyl > anthracenyl > naphthyl > phenyl for the inorganic-organic hybrid nanoflowers. The copper complex of pyrenyl-appended phenanthroline derivative also showed similar biomimetic activity.

Water-mediated reduction of [Cu(dmp)2(CH3CN)]2+: implications of the structure of a classical complex on its activity as an anticancer drug

[Cu(dmp)₂(CH₃CN)]²⁺ can be reduced in acetonitrile containing water due to steric constraints of the ligands. Hydroxyl radicals are produced from water oxidation. We take advantage of this reaction to evaluate the anticancer activity of the complex.

Rosa NM, Costa LAS, Visbal G, Rozental S, Navarro M. Synthesis, characterization and biological evaluation of zinc and copper azasterol complexes against Sporothrix brasiliensis

Characterized zinc– and copper–azasterol complexes acting as promising antifungal agents against Sporothrix brasiliensis. Metal–drug synergism was effectively applied.

Synthesis, characterization and in vitro cytotoxicity studies of novel Cu(II) complex containing zonisamide drug: DNA interaction by multi spectroscopic and molecular docking methods

In this study, the Cu(II) complex with Zonisamide (ZNS) and 1, 10-Phenanthroline (Phen) ligands as an anticancer metallodrug was synthesized and characterized successfully by FT-IR, mass spectrometry, TGA, XPS, AAS, CHNSO, magnetic susceptibility and electrical conductivity. The interaction of Cu(II) complex with DNA was explored through a multi-spectroscopic approach such as fluorescence, UV-vis spectrophotometry, CD spectroscopy, and viscosity measurements. Molecular docking simulation was carried out to gain a deeper insight into the target site of DNA which interacted with the mentioned complex. The competitive binding tests with Hoechst 33258 showed that [CuCl₂(ZNS)(Phen)EtOH].H₂O can bind to the groove site of DNA. The calculated thermodynamic parameters, ΔS° = +201.15 J mol^-1K^-1 and ΔH° = +41.32 kJ mol^-1 confirm that the hydrophobic forces and hydrogen bonding play an essential role in the binding process. The experimental and molecular modeling results demonstrate that the Cu(II) complex binds to DNA through major groove binding. Moreover, the in vitro cytotoxic effects of [CuCl₂(ZNS)(Phen)EtOH].H₂O against B92 cancer cell lines showed better activity in Cu(II) complex in comparison to free ZNS. Therefore, [CuCl₂(ZNS)(Phen)EtOH].H₂O can open a new horizon in the treatment of glioma cancer by ZNS metallodrugs.Communicated by Ramaswamy H. Sarma.

Cu(I) complexes obtained via spontaneous reduction of Cu(II) complexes supported by designed bidentate ligands: bioinspired Cu(I) based catalysts for aromatic hydroxylation

Copper(i) complexes [Cu(L1-7)2](ClO4) (1-7) of bidentate ligands (L1-L7) have been synthesized via spontaneous reduction and characterized as catalysts for aromatic C-H activation using H2O2 as the oxidant. The single crystal X-ray structure of 1 exhibited a distorted tetrahedral geometry. All the copper(i) complexes catalyzed direct hydroxylation of benzene to form phenol with good selectivity up to 98%. The determined kinetic isotope effect (KIE) values, 1.69-1.71, support the involvement of a radical type mechanism. The isotope-labeling experiments using H218O2 showed 92% incorporation of 18O into phenol and confirm that H2O2 is the key oxygen supplier. Overall, the catalytic efficiencies of the complexes are strongly influenced by the electronic and steric factor of the ligand, which is fine-tuned by the ligand architecture. The benzene hydroxylation reaction possibly proceeded via a radical mechanism, which was confirmed by the addition of radical scavengers (TEMPO) to the catalytic reaction that showed a reduction in phenol formation.

Synthesis, characterization, DNA binding, topoisomerase inhibition, and apoptosis induction studies of a novel cobalt(III) complex with a thiosemicarbazone ligand

In this study, 9-anthraldehyde-N(4)-methylthiosemicarbazone (MeATSC) 1 and [Co(phen)2(O2CO)]Cl·6H2O 2 (where phen = 1,10-phenanthroline) were synthesized. [Co(phen)2(O2CO)]Cl·6H2O 2 was used to produce anhydrous [Co(phen)2(H2O)2](NO3)33. Subsequently, anhydrous [Co(phen)2(H2O)2](NO3)33 was reacted with MeATSC 1 to produce [Co(phen)2(MeATSC)](NO3)3·1.5H2O·C2H5OH 4. The ligand, MeATSC 1 and all complexes were characterized by elemental analysis, FT IR, UV-visible, and multinuclear NMR (1H, 13C, and 59Co) spectroscopy, along with HRMS, and conductivity measurements, where appropriate. Interactions of MeATSC 1 and complex 4 with calf thymus DNA (ctDNA) were investigated by carrying out UV-visible spectrophotometric studies. UV-visible spectrophotometric studies revealed weak interactions between ctDNA and the analytes, MeATSC 1 and complex 4 (Kb = 8.1 × 105 and 1.6 × 104 M-1, respectively). Topoisomerase inhibition assays and cleavage studies proved that complex 4 was an efficient catalytic inhibitor of human topoisomerases I and IIα. Based upon the results obtained from the 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay on 4T1-luc metastatic mammary breast cancer cells (IC50 = 34.4 ± 5.2 μM when compared to IC50 = 13.75 ± 1.08 μM for the control, cisplatin), further investigations into the molecular events initiated by exposure to complex 4 were investigated. Studies have shown that complex 4 activated both the apoptotic and autophagic signaling pathways in addition to causing dissipation of the mitochondrial membrane potential (ΔΨm). Furthermore, activation of cysteine-aspartic proteases3 (caspase 3) in a time- and concentration-dependent manner coupled with the ΔΨm, studies implicated the intrinsic apoptotic pathway as the major regulator of cell death mechanism.

Heterocyclic β-keto sulfide derivatives of carvacrol: Synthesis and copper (II) ion reducing capacity

Sixteen β-keto sulfide derivatives of carvacrol (4-19) incorporating phenyl or N, O and S heterocyclic moieties were synthesized in three steps. The relationships between heterocyclic structure and cupric, Cu(II), ion reducing antioxidant capacity (CUPRAC) were examined. Nine of the compounds (8-9 and 13-19) showed better CUPRAC activity than trolox at neutral pH, with trolox equivalent antioxidant capacity (TEAC) coefficients ranging between 1.20 and 1.75. Two derivatives (11-12) showed comparable reducing capacity to trolox, with TEAC values of 0.95 for 11 and 1.02 for 12. Compounds 8-9 and 11-19 were more effective at reducing the Cu(II) ion than ascorbic acid and the parent compound, carvacrol. The most effective antioxidants were those containing an oxadiazole, thiadiazole or triazole moiety. In particular, the methyl thiadiazole derivative (15) had the highest Cu(II) ion reducing capacity, with a TEAC coefficient of 1.73.